Lilly and Novo use aging clocks as trial readouts, hearts up to 4 years younger
omarabudayyeh · x · 2026-11-08
The longevity industry is heating up, per The Economist. Notably, Lilly and Novo Nordisk are now using aging clocks as clinical trial readouts, and patients on their drugs are reading biologically younger — Novo saw hearts up to 4 years younger vs placebo.
More from Research
- Professor slams ICLR reviews from non-experts, calls for qualification stage at top AI conferences — xbresson · 2026-11-08
- Google AI Detects Hypertension From a Regular Smartwatch, Catching 65.8% vs 55.3% for Cuff — emmanuelvivier · 2026-11-08
- Impagliazzo's five worlds table resurfaces: which complexity universe do we live in? — matthew_d_green · 2026-11-08
- YC Paper Club: Falling Sequencing Costs Turn Cancer Care Into a Per-Patient Data Problem — Y Combinator · 2026-11-08
- Dev builds llm-beliefs: maps every LLM's yes/no censorship beliefs per country — -p-e-w- · 2026-11-08
- Researchers propose centralized AI peer review over reviewers using LLMs ad hoc — JessicaHullman · 2026-11-08